DE69527182T2 - Zusammensetzung zur Verminderung von Nephrotoxizität durch Medikamente, die kugelförmige Aktivkohle enthalten - Google Patents

Zusammensetzung zur Verminderung von Nephrotoxizität durch Medikamente, die kugelförmige Aktivkohle enthalten

Info

Publication number
DE69527182T2
DE69527182T2 DE69527182T DE69527182T DE69527182T2 DE 69527182 T2 DE69527182 T2 DE 69527182T2 DE 69527182 T DE69527182 T DE 69527182T DE 69527182 T DE69527182 T DE 69527182T DE 69527182 T2 DE69527182 T2 DE 69527182T2
Authority
DE
Germany
Prior art keywords
composition
activated carbon
spherical activated
drugs containing
containing spherical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69527182T
Other languages
English (en)
Other versions
DE69527182D1 (de
Inventor
Michihito Ise
Hideo Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Application granted granted Critical
Publication of DE69527182D1 publication Critical patent/DE69527182D1/de
Publication of DE69527182T2 publication Critical patent/DE69527182T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69527182T 1994-11-15 1995-11-10 Zusammensetzung zur Verminderung von Nephrotoxizität durch Medikamente, die kugelförmige Aktivkohle enthalten Expired - Lifetime DE69527182T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30542894 1994-11-15

Publications (2)

Publication Number Publication Date
DE69527182D1 DE69527182D1 (de) 2002-08-01
DE69527182T2 true DE69527182T2 (de) 2002-11-28

Family

ID=17945021

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527182T Expired - Lifetime DE69527182T2 (de) 1994-11-15 1995-11-10 Zusammensetzung zur Verminderung von Nephrotoxizität durch Medikamente, die kugelförmige Aktivkohle enthalten

Country Status (7)

Country Link
US (1) US5573761A (de)
EP (1) EP0711561B1 (de)
KR (1) KR960016892A (de)
CN (1) CN1101193C (de)
AU (1) AU680155B2 (de)
CA (1) CA2162086A1 (de)
DE (1) DE69527182T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289549A3 (de) 1999-10-01 2011-06-15 Immunogen, Inc. Immunokonjugate für Krebsbehandlung
US6830753B2 (en) * 2001-04-11 2004-12-14 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
JP3522708B2 (ja) * 2001-04-11 2004-04-26 呉羽化学工業株式会社 経口投与用吸着剤
ATE335495T1 (de) * 2002-10-09 2006-09-15 Kureha Corp Pharmazeutische zubereitung enthaltend poröse sphärische kohlenstoffhaltige teilchen und deren verwendung zur behandlung von leber- und nierenerkrankungen
CN100411630C (zh) * 2002-10-10 2008-08-20 株式会社吴羽 口服用吸附剂和含有上述口服用吸附剂的药物组合物
JP3672200B2 (ja) * 2002-11-01 2005-07-13 呉羽化学工業株式会社 経口投与用吸着剤
US7651974B2 (en) 2002-11-01 2010-01-26 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
CN1691949B (zh) * 2002-11-01 2012-10-03 株式会社吴羽 口服用吸附剂、以及肾脏疾病治疗或预防剂和肝脏疾病治疗或预防剂
CN1615908B (zh) * 2003-10-22 2011-09-28 株式会社吴羽 口服给药用吸附剂、以及肾病治疗或预防剂、和肝病治疗或预防剂
TWI370013B (en) 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
TWI385120B (zh) * 2004-04-02 2013-02-11 Kureha Corp 球狀活性碳之製造方法
TWI370012B (en) 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
US20070191571A1 (en) * 2006-02-14 2007-08-16 Sink Chester W Resol beads, methods of making them, and methods of using them
US20070191572A1 (en) * 2006-02-14 2007-08-16 Tustin Gerald C Resol beads, methods of making them, and methods of using them
US8247072B2 (en) 2006-02-14 2012-08-21 Eastman Chemical Company Resol beads, methods of making them and methods of using them
US20070207917A1 (en) * 2006-02-14 2007-09-06 Chester Wayne Sink Activated carbon monoliths and methods of making them
US10791592B2 (en) 2015-11-19 2020-09-29 Haier Us Appliance Solutions, Inc. Method for operating fans within an appliance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3934007A (en) * 1973-06-25 1976-01-20 American Cyanamid Company Method of removing toxic substances from the intestinal tract by the use of a surfactant and a sorbent
US4761284A (en) * 1977-12-27 1988-08-02 Kureha Kagaku Kogy Kabushiki Kaisha Antidote including activated carbon particles
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
JP3518878B2 (ja) * 1992-10-29 2004-04-12 呉羽化学工業株式会社 抗ネフローゼ症候群剤

Also Published As

Publication number Publication date
KR960016892A (ko) 1996-06-17
DE69527182D1 (de) 2002-08-01
CN1101193C (zh) 2003-02-12
CA2162086A1 (en) 1996-05-16
AU3784395A (en) 1996-05-23
EP0711561B1 (de) 2002-06-26
AU680155B2 (en) 1997-07-17
EP0711561A3 (de) 1997-12-17
CN1132075A (zh) 1996-10-02
US5573761A (en) 1996-11-12
EP0711561A2 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
DE69527182T2 (de) Zusammensetzung zur Verminderung von Nephrotoxizität durch Medikamente, die kugelförmige Aktivkohle enthalten
ATE355266T1 (de) Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen
HUP9901209A3 (en) Opioid-like peptide compounds, process for producing them and pharmaceutical compositions containing them
DE69813958D1 (de) Ungesättigte Copolymere, Verfahren zu deren Herstellung und Mischungen, die diese enthalten
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
DE69601765T2 (de) Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
DE69628188D1 (de) Monoolefin-polyen-copolymere, verfahren zu ihrer herstellung, zusammensetzungen die diese enthalten und daraus hergestellte formteile
HUP0001153A3 (en) Chemically modified polypeptides, process for producing thereof, pharmaceutical compositions comprising these polypeptides and their use
DE59610280D1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE99268T1 (de) Verfahren zur herstellung von agglomeraten von aktiviertem aluminiumoxid, auf diese weise hergestellte agglomerate und vorrichtung zu ihrer herstellung.
FR2743077B1 (fr) Polyamide et un procede de fabrication de celui-ci, et des compositions le contenant
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
IL139529A0 (en) Platinum complexes, processes for the preparation thereof and pharmaceutical compositions containing the same
ATA69888A (de) Neue substituierte benzamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese benzamide enthalten
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
HUP9602072A3 (en) Substituted cinnamic acid guanidines, process for producing them, and pharmaceutical compositions containing them
DE69932182D1 (de) Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden.
DE69806675D1 (de) Feste Arzneizubereitung aus Vitaminen und Kalzium, Verfahren zu ihrer Herstellung und ihre Anwendung
CA2185443A1 (en) Method for the separation and purification of fullerenes
IL139528A0 (en) Platinum complexes, processes for the preparation thereof and pharmaceutical compositions containing the same
ATE13053T1 (de) Neue oximaether, verfahren zu ihrer herstellung, mittel die die neuen oximaether enthalten und ihre verwendung.
DE68913783D1 (de) Aromatische Polyäther, fluoreszierende Harzzusammensetzungen, die diese enthalten, und Verfahren für ihre Herstellung.
DE59400221D1 (de) Vorrichtung für die Entnahme, Zubereitung und Verteilung von Viehfutter
HUT73982A (en) Substituted benzol-sulfonyl-ureas and -thioureas, process for producing them, pharmaceutical compositions containing them, and their use
ZA978083B (en) Modified amino acids, medicaments containing these compounds and processes for their preparation.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: KUREHA CORP., TOKYO/TOKIO, JP